Drug name - Ubrelvy
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9499545 | ALLERGAN | Piperidinone carboxamide azaindane CGRP receptor antagonists |
Nov, 2031
(9 years from now) | |
| US8912210 | ALLERGAN | Piperidinone carboxamide azaindane CGRP receptor antagonists |
Nov, 2031
(9 years from now) | |
| US8754096 | ALLERGAN | Piperidinone carboxamide azaindane CGRP receptor antagonists |
Jul, 2032
(9 years from now) | |
| CN103328478B | ALLERGAN | Piperidone Carboxamide Nitrogen Mixed Indene Into Cgrp Receptor Antagonists |
Nov, 2031
(9 years from now) | |
| CN103328478A | ALLERGAN | Piperidones Carboxamide Indane Cgrp Receptor Antagonist |
Nov, 2031
(9 years from now) | |
| IN201303390P4 | ALLERGAN | Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists |
Nov, 2031
(9 years from now) | |
| IN289826B | ALLERGAN | Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists |
Nov, 2031
(9 years from now) | |
| EP2638042B1 | ALLERGAN | Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists |
Nov, 2031
(9 years from now) | |
| EP2638042A1 | ALLERGAN | Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists |
Nov, 2031
(9 years from now) | |
| EP2821407A1 | ALLERGAN | Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists |
Nov, 2031
(9 years from now) | |
| EP2821407B1 | ALLERGAN | Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists |
Nov, 2031
(9 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9833448 | ALLERGAN | Piperidinone carboxamide azaindane CGRP receptor antagonists |
Nov, 2031
(9 years from now) | |
| US10117836 | ALLERGAN | Tablet formulation for CGRP active compounds |
Jan, 2035
(12 years from now) | |
Drugs and Companies using UBROGEPANT ingredient
Treatment: Acute treatment of migraine with or without aura in adults
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 50MG | TABLET;ORAL | Prescription |
| 100MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.